Aloxiprin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Aloxiprin
Accession Number
DB13509
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
Not Available
Categories
UNII
6QT214X4XU
CAS number
9014-67-9
Weight
Average: 282.119
Monoisotopic: 281.9900796
Chemical Formula
C9H8Al2O7
InChI Key
MXCPYJZDGPQDRA-UHFFFAOYSA-N
InChI
InChI=1S/C9H8O4.2Al.3O/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;;;;;/h2-5H,1H3,(H,11,12);;;;;/q;2*+3;3*-2
IUPAC Name
dialuminium(3+) ion 2-(acetyloxy)benzoic acid trioxidandiide
SMILES
[O--].[O--].[O--].[Al+3].[Al+3].CC(=O)OC1=CC=CC=C1C(O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
16-BromoepiandrosteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with 16-Bromoepiandrosterone.Investigational
19-norandrostenedioneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with 19-norandrostenedione.Experimental, Illicit
5-androstenedioneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with 5-androstenedione.Experimental, Illicit
AcarboseAloxiprin may increase the hypoglycemic activities of Acarbose.Approved, Investigational
AlbiglutideAloxiprin may increase the hypoglycemic activities of Albiglutide.Approved
AlclometasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Alclometasone.Approved
AldosteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Aldosterone.Experimental, Investigational
AlogliptinAloxiprin may increase the hypoglycemic activities of Alogliptin.Approved
AmcinonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Amcinonide.Approved
AndrostenedioneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Androstenedione.Experimental, Illicit
AnecortaveThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Anecortave.Investigational
anecortave acetateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with anecortave acetate.Investigational
Antithrombin III humanAloxiprin may increase the anticoagulant activities of Antithrombin III human.Approved
ApixabanAloxiprin may increase the anticoagulant activities of Apixaban.Approved
ArdeparinAloxiprin may increase the anticoagulant activities of Ardeparin.Approved, Investigational, Withdrawn
AtamestaneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Atamestane.Investigational
AzosemideThe therapeutic efficacy of Azosemide can be decreased when used in combination with Aloxiprin.Investigational
BecaplerminAloxiprin may increase the anticoagulant activities of Becaplermin.Approved, Investigational
Beclomethasone dipropionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Beclomethasone dipropionate.Approved, Investigational
BenazeprilThe therapeutic efficacy of Benazepril can be decreased when used in combination with Aloxiprin.Approved, Investigational
BetamethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Betamethasone.Approved, Vet Approved
BivalirudinAloxiprin may increase the anticoagulant activities of Bivalirudin.Approved, Investigational
BromocriptineAloxiprin may increase the hypoglycemic activities of Bromocriptine.Approved, Investigational
BudesonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Budesonide.Approved
BumetanideThe therapeutic efficacy of Bumetanide can be decreased when used in combination with Aloxiprin.Approved
CanagliflozinAloxiprin may increase the hypoglycemic activities of Canagliflozin.Approved
CandoxatrilThe therapeutic efficacy of Candoxatril can be decreased when used in combination with Aloxiprin.Experimental
CaptoprilThe therapeutic efficacy of Captopril can be decreased when used in combination with Aloxiprin.Approved
CertoparinAloxiprin may increase the anticoagulant activities of Certoparin.Approved, Investigational
ChlorpropamideAloxiprin may increase the hypoglycemic activities of Chlorpropamide.Approved, Investigational
ChlorthalidoneThe therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Aloxiprin.Approved
CiclesonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ciclesonide.Approved, Investigational
CilazaprilThe therapeutic efficacy of Cilazapril can be decreased when used in combination with Aloxiprin.Approved
Citric AcidAloxiprin may increase the anticoagulant activities of Citric Acid.Approved, Nutraceutical, Vet Approved
ClobetasolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clobetasol.Approved, Investigational
Clobetasol propionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clobetasol propionate.Approved
ClobetasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clobetasone.Approved
ClocortoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clocortolone.Approved
Cortexolone 17α-propionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Cortexolone 17α-propionate.Investigational
CorticosteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Corticosterone.Experimental
Cortisone acetateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Cortisone acetate.Approved, Investigational
DapagliflozinAloxiprin may increase the hypoglycemic activities of Dapagliflozin.Approved
DarexabanAloxiprin may increase the anticoagulant activities of Darexaban.Investigational
DeflazacortThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Deflazacort.Approved, Investigational
DelaprilThe therapeutic efficacy of Delapril can be decreased when used in combination with Aloxiprin.Experimental
DesirudinAloxiprin may increase the anticoagulant activities of Desirudin.Approved
DesonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desonide.Approved, Investigational
DesoximetasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desoximetasone.Approved
Desoxycorticosterone acetateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desoxycorticosterone acetate.Approved
Desoxycorticosterone PivalateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desoxycorticosterone Pivalate.Experimental, Vet Approved
DexamethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Dexamethasone.Approved, Investigational, Vet Approved
Dexamethasone isonicotinateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Dexamethasone isonicotinate.Vet Approved
DextranAloxiprin may increase the anticoagulant activities of Dextran.Approved, Investigational, Vet Approved
DiflorasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Diflorasone.Approved
DifluocortoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Difluocortolone.Approved, Investigational, Withdrawn
DifluprednateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Difluprednate.Approved
DiltiazemDiltiazem may increase the anticoagulant activities of Aloxiprin.Approved, Investigational
DisopyramideAloxiprin may increase the hypoglycemic activities of Disopyramide.Approved
DulaglutideAloxiprin may increase the hypoglycemic activities of Dulaglutide.Approved, Investigational
Edetic AcidAloxiprin may increase the anticoagulant activities of Edetic Acid.Approved, Vet Approved
EdoxabanAloxiprin may increase the anticoagulant activities of Edoxaban.Approved
EmpagliflozinAloxiprin may increase the hypoglycemic activities of Empagliflozin.Approved
EnalaprilThe therapeutic efficacy of Enalapril can be decreased when used in combination with Aloxiprin.Approved, Vet Approved
EnalaprilatThe therapeutic efficacy of Enalaprilat can be decreased when used in combination with Aloxiprin.Approved
EnoxaparinAloxiprin may increase the anticoagulant activities of Enoxaparin.Approved
EquileninThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Equilenin.Experimental
EquilinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Equilin.Approved
EstroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Estrone.Approved
Estrone sulfateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Estrone sulfate.Approved
Etacrynic acidThe therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Aloxiprin.Approved, Investigational
ExenatideAloxiprin may increase the hypoglycemic activities of Exenatide.Approved, Investigational
Ferulic acidAloxiprin may increase the anticoagulant activities of Ferulic acid.Experimental
FluasteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluasterone.Investigational
FludrocortisoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fludrocortisone.Approved, Investigational
FlumethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Flumethasone.Approved, Vet Approved
FlunisolideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Flunisolide.Approved, Investigational
Fluocinolone AcetonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocinolone Acetonide.Approved, Investigational, Vet Approved
FluocinonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocinonide.Approved, Investigational
FluocortoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocortolone.Approved, Withdrawn
FluorometholoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluorometholone.Approved, Investigational
FluprednideneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluprednidene.Approved, Withdrawn
FluprednisoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluprednisolone.Approved
FlurandrenolideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Flurandrenolide.Approved
FluticasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluticasone.Approved, Experimental, Investigational
Fluticasone furoateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluticasone furoate.Approved
Fluticasone propionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluticasone propionate.Approved
FondaparinuxAloxiprin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Fondaparinux sodiumAloxiprin may increase the anticoagulant activities of Fondaparinux sodium.Approved, Investigational
FormestaneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Formestane.Approved, Investigational, Withdrawn
FosinoprilThe therapeutic efficacy of Fosinopril can be decreased when used in combination with Aloxiprin.Approved
FurosemideThe therapeutic efficacy of Furosemide can be decreased when used in combination with Aloxiprin.Approved, Vet Approved
GabexateAloxiprin may increase the anticoagulant activities of Gabexate.Investigational
GliclazideAloxiprin may increase the hypoglycemic activities of Gliclazide.Approved
GlimepirideAloxiprin may increase the hypoglycemic activities of Glimepiride.Approved
GlipizideAloxiprin may increase the hypoglycemic activities of Glipizide.Approved, Investigational
GlyburideAloxiprin may increase the hypoglycemic activities of Glyburide.Approved
HalcinonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Halcinonide.Approved, Investigational, Withdrawn
HE3286The risk or severity of adverse effects can be increased when Aloxiprin is combined with HE3286.Investigational
HydrocortisoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Hydrocortisone.Approved, Vet Approved
HydroflumethiazideThe therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Aloxiprin.Approved, Investigational
IdraparinuxAloxiprin may increase the anticoagulant activities of Idraparinux.Investigational
ImidaprilThe therapeutic efficacy of Imidapril can be decreased when used in combination with Aloxiprin.Investigational
Insulin AspartAloxiprin may increase the hypoglycemic activities of Insulin Aspart.Approved
Insulin DetemirAloxiprin may increase the hypoglycemic activities of Insulin Detemir.Approved
Insulin GlargineAloxiprin may increase the hypoglycemic activities of Insulin Glargine.Approved
Insulin GlulisineAloxiprin may increase the hypoglycemic activities of Insulin Glulisine.Approved
Insulin HumanAloxiprin may increase the hypoglycemic activities of Insulin Human.Approved, Investigational
Insulin LisproAloxiprin may increase the hypoglycemic activities of Insulin Lispro.Approved
IstaroximeThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Istaroxime.Investigational
LepirudinAloxiprin may increase the anticoagulant activities of Lepirudin.Approved
LetaxabanAloxiprin may increase the anticoagulant activities of Letaxaban.Investigational
LiraglutideAloxiprin may increase the hypoglycemic activities of Liraglutide.Approved
LisinoprilThe therapeutic efficacy of Lisinopril can be decreased when used in combination with Aloxiprin.Approved, Investigational
LoteprednolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Loteprednol.Approved
ME-609The risk or severity of adverse effects can be increased when Aloxiprin is combined with ME-609.Investigational
MecaserminAloxiprin may increase the hypoglycemic activities of Mecasermin.Approved, Investigational
MedrysoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Medrysone.Approved
MelagatranAloxiprin may increase the anticoagulant activities of Melagatran.Experimental
MelengestrolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Melengestrol.Vet Approved
MetforminAloxiprin may increase the hypoglycemic activities of Metformin.Approved
MethyclothiazideThe therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Aloxiprin.Approved
MethylprednisoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Methylprednisolone.Approved, Vet Approved
MifepristoneAloxiprin may increase the hypoglycemic activities of Mifepristone.Approved, Investigational
MiglitolAloxiprin may increase the hypoglycemic activities of Miglitol.Approved
MoexiprilThe therapeutic efficacy of Moexipril can be decreased when used in combination with Aloxiprin.Approved
MometasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Mometasone.Approved, Vet Approved
NadroparinAloxiprin may increase the anticoagulant activities of Nadroparin.Approved, Investigational
NafamostatAloxiprin may increase the anticoagulant activities of Nafamostat.Approved, Investigational
NateglinideAloxiprin may increase the hypoglycemic activities of Nateglinide.Approved, Investigational
NCX 1022The risk or severity of adverse effects can be increased when Aloxiprin is combined with NCX 1022.Investigational
Oleoyl-estroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Oleoyl-estrone.Investigational
OmapatrilatThe therapeutic efficacy of Omapatrilat can be decreased when used in combination with Aloxiprin.Investigational
OtamixabanAloxiprin may increase the anticoagulant activities of Otamixaban.Investigational
ParamethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Paramethasone.Approved
Pentaerythritol TetranitrateAloxiprin may increase the anticoagulant activities of Pentaerythritol Tetranitrate.Approved
PentamidineAloxiprin may increase the hypoglycemic activities of Pentamidine.Approved, Investigational
Pentosan PolysulfateAloxiprin may increase the anticoagulant activities of Pentosan Polysulfate.Approved
PerindoprilThe therapeutic efficacy of Perindopril can be decreased when used in combination with Aloxiprin.Approved
PioglitazoneAloxiprin may increase the hypoglycemic activities of Pioglitazone.Approved, Investigational
PiretanideThe therapeutic efficacy of Piretanide can be decreased when used in combination with Aloxiprin.Approved
Potassium CitrateAloxiprin may increase the anticoagulant activities of Potassium Citrate.Approved, Investigational, Vet Approved
PramlintideAloxiprin may increase the hypoglycemic activities of Pramlintide.Approved, Investigational
PrasteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prasterone.Approved, Investigational, Nutraceutical
Prasterone sulfateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prasterone sulfate.Investigational
PrednicarbateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednicarbate.Approved, Investigational
PrednisoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisolone.Approved, Vet Approved
PrednisoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisone.Approved, Vet Approved
PregnenoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Pregnenolone.Approved, Experimental, Investigational
Protein S humanAloxiprin may increase the anticoagulant activities of Protein S human.Approved
ProtocatechualdehydeAloxiprin may increase the anticoagulant activities of Protocatechualdehyde.Approved
QuinaprilThe therapeutic efficacy of Quinapril can be decreased when used in combination with Aloxiprin.Approved, Investigational
QuinethazoneThe therapeutic efficacy of Quinethazone can be decreased when used in combination with Aloxiprin.Approved
QuinineAloxiprin may increase the hypoglycemic activities of Quinine.Approved
RamiprilThe therapeutic efficacy of Ramipril can be decreased when used in combination with Aloxiprin.Approved
RepaglinideAloxiprin may increase the hypoglycemic activities of Repaglinide.Approved, Investigational
RescinnamineThe therapeutic efficacy of Rescinnamine can be decreased when used in combination with Aloxiprin.Approved
ReviparinAloxiprin may increase the anticoagulant activities of Reviparin.Approved, Investigational
RimexoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Rimexolone.Approved
RivaroxabanAloxiprin may increase the anticoagulant activities of Rivaroxaban.Approved
SaxagliptinAloxiprin may increase the hypoglycemic activities of Saxagliptin.Approved
SitagliptinAloxiprin may increase the hypoglycemic activities of Sitagliptin.Approved, Investigational
Sodium CitrateAloxiprin may increase the anticoagulant activities of Sodium Citrate.Approved, Investigational
SpiraprilThe therapeutic efficacy of Spirapril can be decreased when used in combination with Aloxiprin.Approved
SulfadiazineAloxiprin may increase the hypoglycemic activities of Sulfadiazine.Approved, Investigational, Vet Approved
SulfamethoxazoleAloxiprin may increase the hypoglycemic activities of Sulfamethoxazole.Approved
SulfisoxazoleAloxiprin may increase the hypoglycemic activities of Sulfisoxazole.Approved, Vet Approved
SunitinibAloxiprin may increase the hypoglycemic activities of Sunitinib.Approved, Investigational
TemocaprilThe therapeutic efficacy of Temocapril can be decreased when used in combination with Aloxiprin.Experimental, Investigational
TixocortolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Tixocortol.Approved, Withdrawn
TolazamideAloxiprin may increase the hypoglycemic activities of Tolazamide.Approved, Investigational
TolbutamideAloxiprin may increase the hypoglycemic activities of Tolbutamide.Approved, Investigational
TorasemideThe therapeutic efficacy of Torasemide can be decreased when used in combination with Aloxiprin.Approved
TrandolaprilThe therapeutic efficacy of Trandolapril can be decreased when used in combination with Aloxiprin.Approved
TriamcinoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Triamcinolone.Approved, Vet Approved
TrichlormethiazideThe therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Aloxiprin.Approved, Vet Approved
TroxerutinAloxiprin may increase the anticoagulant activities of Troxerutin.Investigational
UlobetasolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ulobetasol.Approved
Valproic AcidThe serum concentration of Valproic Acid can be increased when it is combined with Aloxiprin.Approved, Investigational
VerapamilVerapamil may increase the anticoagulant activities of Aloxiprin.Approved
XimelagatranAloxiprin may increase the anticoagulant activities of Ximelagatran.Approved, Investigational, Withdrawn
ZofenoprilThe therapeutic efficacy of Zofenopril can be decreased when used in combination with Aloxiprin.Experimental
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
32698107
Wikipedia
Aloxiprin
ATC Codes
N02BA02 — AloxiprinB01AC15 — Aloxiprin

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility36.2 mg/mLALOGPS
logP1.19ALOGPS
logP1.24ChemAxon
logS-0.76ALOGPS
pKa (Strongest Acidic)3.41ChemAxon
pKa (Strongest Basic)-7.1ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area63.6 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity44.45 m3·mol-1ChemAxon
Polarizability16.96 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as acylsalicylic acids. These are o-acylated derivatives of salicylic acid.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Acylsalicylic acids
Alternative Parents
Phenol esters / Benzoic acids / Phenoxy compounds / Benzoyl derivatives / Dicarboxylic acids and derivatives / Carboxylic acid esters / Carboxylic acids / Organic oxides / Organic aluminium salts / Hydrocarbon derivatives
show 1 more
Substituents
Acylsalicylic acid / Phenol ester / Benzoic acid / Phenoxy compound / Benzoyl / Dicarboxylic acid or derivatives / Carboxylic acid ester / Carboxylic acid derivative / Carboxylic acid / Organic oxygen compound
show 7 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available

Drug created on June 23, 2017 14:43 / Updated on June 02, 2018 08:51